Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Switzerland
/
Healthcare
Create a narrative
Straumann Holding Community
SWX:STMN Community
1
Narratives
written by author
0
Comments
on narratives written by author
16
Fair Values set
on narratives written by author
Create a narrative
Straumann Holding
Popular
Undervalued
Overvalued
Community Investing Ideas
Straumann Holding
AN
AnalystConsensusTarget
Consensus Narrative from 21 Analysts
iEXCEL And AXS Platforms Will Drive Market Share Gains In Implantology
Key Takeaways Investment in innovation and digital transformation, such as the iEXCEL implant system and AXS platform, drives market share, operational efficiency, and gross margins. Strategic expansion in underpenetrated firms and regions, emphasizing education and local manufacturing, enhances revenue potential, affordability, and profitability.
View narrative
CHF 133.05
FV
28.2% undervalued
intrinsic discount
10.13%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
7 days ago
author updated this narrative
Your Valuation for
STMN
STMN
Straumann Holding
Your Fair Value
CHF
Current Price
CHF 95.50
20.1% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
4b
2015
2018
2021
2024
2025
2027
2030
Revenue CHF 3.9b
Earnings CHF 716.3m
Advanced
Set Fair Value